Reckitt Benckiser Stock - New non-executive directors and midweek strategy focus

Reckitt Benckiser adds two seasoned non-executive directors to its board from July, while investors look midweek at how the consumer health group is steering strategy, costs and brand strength in a competitive global market.

Edited by ad hoc news Operations & Strategy Desk. Verified prior to publication on 06/17/2026, 19:38 CET. Details in the imprint.

Reckitt Benckiser (GB00B24CGK77) has appointed Deborah Waterhouse and Gavin Patterson as new non-executive directors to strengthen its board. The two appointments, highlighted in a 06/17/2026 update, take effect on 07/01/2026 according to a detailed report from DirectorsTalk Interviews.

What the board changes add

Reckitt Benckiser confirmed that Deborah Waterhouse and Gavin Patterson will join the board as non-executive directors from 07/01/2026, bringing additional healthcare and media experience to the group’s governance structure, as reported by DirectorsTalk Interviews on 06/17/2026.

Waterhouse has extensive experience in pharmaceuticals and consumer health, while Patterson brings a background in telecommunications and digital media, which can support brand-building and digital engagement priorities for the company’s portfolio.

Midweek focus on operations and strategy

Beyond governance, investors are watching how Reckitt Benckiser executes its strategy in hygiene, health and nutrition, with emphasis on sustaining pricing power and volume resilience across major brands such as Dettol, Durex and Nurofen in competitive global markets.

The company has stressed in recent updates that productivity programs and disciplined cost management remain central, as outlined in its latest investor materials, to protect margins while it continues to invest in innovation, marketing and emerging-market expansion.

How the company makes money

Reckitt Benckiser generates most of its revenue from branded consumer products in hygiene, health and nutrition, selling everyday items like disinfectants, over-the-counter medicines, infant nutrition and sexual health products across supermarkets, pharmacies and online channels worldwide.

Where the stock trades today

The shares of Reckitt Benckiser (GB00B24CGK77) trade on the London Stock Exchange in GBP; the latest available quote and market data can be accessed via the company’s official investor relations page as of the most recent trading session.

Key facts on Reckitt Benckiser stock

• Company: Reckitt Benckiser Group plc
• ISIN: GB00B24CGK77
• Venue: London Stock Exchange
• Sector / Industry: Consumer Staples / Household & Personal Products

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.